AAAAAA

   
Results: 1-3 |
Results: 3
Novel promoter polymorphism in insulin-like growth factor-binding protein-3: Correlation with serum levels and interaction with known regulators
Authors: Deal, C Ma, J Wilkin, F Paquette, J Rozen, F Ge, B Hudson, T Stampfer, M Pollak, M
Citation: C. Deal et al., Novel promoter polymorphism in insulin-like growth factor-binding protein-3: Correlation with serum levels and interaction with known regulators, J CLIN END, 86(3), 2001, pp. 1274-1280
Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome
Authors: Foulkes, WD Chappuis, PO Wong, N Brunet, JS Vesprini, D Rozen, F Yuan, ZQ Pollak, MN Kuperstein, G Narod, SA Begin, LR
Citation: Wd. Foulkes et al., Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome, ANN ONCOL, 11(3), 2000, pp. 307-313
Inhibition of insulin-like growth factor I receptor signaling by the vitamin D analogue EB1089 in MCF-7 breast cancer cells: A role for insulin-like growth factor binding proteins
Authors: Rozen, F Pollak, M
Citation: F. Rozen et M. Pollak, Inhibition of insulin-like growth factor I receptor signaling by the vitamin D analogue EB1089 in MCF-7 breast cancer cells: A role for insulin-like growth factor binding proteins, INT J ONCOL, 15(3), 1999, pp. 589-594
Risultati: 1-3 |